2019
DOI: 10.1002/ijc.31984
|View full text |Cite
|
Sign up to set email alerts
|

Multigene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non‐CDKN2A/CDK4 melanoma families

Abstract: Germline mutations in the major melanoma susceptibility gene CDKN2A explain genetic predisposition in only 10–40% of melanoma‐prone families. In our study we comprehensively characterized 488 melanoma cases from 451 non‐ CDKN2A/CDK4 families for mutations in 30 established and candidate melanoma susceptibility genes using a custom‐designed targeted gene panel approach. We identified (likely) pathogenic variants in established melanoma susceptibility genes in 18 fam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
32
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(36 citation statements)
references
References 49 publications
4
32
0
Order By: Relevance
“…The p.V443I variant has been previously observed in OCA patients with PWS or AS (Hutton & Spritz, ; Lee et al, ), compound heterozygous individuals with OCA2 (Lasseaux et al, ) and in an unrelated CM family in the UK (Hawkes et al, ). Additionally, the pathogenic p.N489D and p.V443I variants, among other rare OCA2 variants not present in our cohort, were reported in a Dutch CM family cohort, providing further evidence of the role of OCA2 as a CM medium penetrance or modifier susceptibility gene (Potjer et al, ).…”
Section: Heterozygous Germline Variants In Oca Genes: Variants In Ocasupporting
confidence: 78%
“…The p.V443I variant has been previously observed in OCA patients with PWS or AS (Hutton & Spritz, ; Lee et al, ), compound heterozygous individuals with OCA2 (Lasseaux et al, ) and in an unrelated CM family in the UK (Hawkes et al, ). Additionally, the pathogenic p.N489D and p.V443I variants, among other rare OCA2 variants not present in our cohort, were reported in a Dutch CM family cohort, providing further evidence of the role of OCA2 as a CM medium penetrance or modifier susceptibility gene (Potjer et al, ).…”
Section: Heterozygous Germline Variants In Oca Genes: Variants In Ocasupporting
confidence: 78%
“…In co-segregation analysis of the extended pedigree, both of these OCA2 deleterious alleles were analyzed as melanoma risk variants, with an OR of 6.55. In a recent report of a multi-gene panel screening of Dutch non-CDKN2A/CDK4 melanoma families, 9 rare pathogenic variants of OCA2 were found [65]. The p.V443I and p.N489D alleles were detected at double the frequency of Dutch GoNL reference database controls (1.8% and 0.71%) similar to the frequency of these alleles in all melanoma cases reported here (1.81% and 0.09%, S1 Table).…”
Section: Plos Onesupporting
confidence: 78%
“…However, the frequency of the p.N489D allele did not statistically differ according to disease status in the BNMS cohort. Notably, a p.V443I homozygous Dutch patient was reported as having 3 primary melanomas, as was another individual who was biallelic for OCA2 [65]. In another recent study of Australian and Danish melanoma families [66], the OCA2 p.V443I frequency was increased in cases (6 carriers in 107 cases, crude allele frequency 2.8%) and the OCA2 p.N489D was detected in three cases from one pedigree (1.4%).…”
Section: Plos Onementioning
confidence: 96%
“…The increased risk of only one or a few tumour types is common in monogenic tumour predisposition syndromes 48. Furthermore, the absence of any NEK11 mutation in 488 Dutch familial melanoma cases49 warrants screening for NEK11 mutations in melanoma families worldwide in order to confirm the importance of NEK11 as a melanoma-susceptibility gene.…”
Section: Discussionmentioning
confidence: 99%